Category Archives: FCA
Remedies for a Healthy Patient
One thing that FCA is good at is trailing its views. So it is that the Asset Management Market Study Final Report contains no real surprises. But lack of surprise does not mean lack of impact. These measures will certainly …
Click here to read the rest of this entry
Inflaming June
As temperatures soar around the country and June looks as though it might at last live up to its reputation, the investment industry waits with bated breath for two documents that will be key to life in 2018. As all …
Click here to read the rest of this entry
Best Execution – Again
It would not be entirely fair to accuse the Regulator of banging-on endlessly about best execution. Until the publication of the Thematic Review in 2014 (TR 14/13), it had said nothing about it for years. And there was precious little …
Click here to read the rest of this entry
Tagged in: Best Execution, competition, ESMA, FCA visit, MiFID